2011•Chinese Journal of Hospital PharmacyRequires access

Nephrotoxicity of gemcitabine on human breast cancer cell MCF-7 and humanermbryonic kidney cell 293 invitro

Xiao Jia Yi

Open publisher page 0 citations

Abstract

OBJECTIVE To demonstrate the antiproliferative effect of gemcitabine on human ermbryonic kidney cell 293 and human breast cancer cell MCF-7 in vitro.METHODS The inhibiting rate of gemcitabine on human ermbryonic kidney cell 293 and human breast cancer cell MCF-7 was detected by MTT assay.Their IC50 values for the effect of gemcitabine were compared.The cell growth curve was designed.The contents of SOD,MDA and LDH in cultural supernate were measured by ultraviolet spectrophotometry.RESULTS Gemcitabine significantly inhibited the proliferation of human breast cancer cell MCF-7 in vitro.It also inhibited the proliferation of human ermbryonic kidney cell 293.Their chemotherapeutic index were 26.907(24 h),15.307(48 h) and 10.264(72 h).CONCLUSION Gemcitabine is cytotoxic in human breast cancer cell MCF-7,and inhibits the proliferation of human ermbryonic kidney cell 293.

About this research paper

What this paper is about

OBJECTIVE To demonstrate the antiproliferative effect of gemcitabine on human ermbryonic kidney cell 293 and human breast cancer cell MCF-7 in vitro.METHODS The inhibiting rate of gemcitabine on human ermbryonic kidney cell 293 and human breast cancer cell MCF-7 was detected by MTT assay.Their IC50 values for the effect of gemcitabine were compared.The cell growth curve was designed.The contents of SOD,MDA and LDH in cultural supernate were measured by ultraviolet spectrophotometry.RESULTS Gemcitabine significantly inhibited the proliferation of human breast cancer cell MCF-7 in vitro.It also inhibited the proliferation of human ermbryonic kidney cell 293.Their chemotherapeutic index were 26.907(24 h),15.307(48 h) and 10.264(72 h).CONCLUSION Gemcitabine is cytotoxic in human breast cancer cell MCF-7,and inhibits the proliferation of human ermbryonic kidney cell 293.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To demonstrate the antiproliferative effect of gemcitabine on human ermbryonic kidney cell 293 and human breast cancer cell MCF-7 in vitro.METHODS The inhibiting rate of gemcitabine on human ermbryonic kidney cell 293 and human breast cancer cell MCF-7 was detected by MTT assay.Their IC50 values for the effect of gemcitabine were compared.The cell growth curve was designed.The contents of SOD,MDA and LDH in cultural supernate were measured by ultraviolet spectrophotometry.RESULTS Gemcitabine significantly inhibited the proliferation of human breast cancer cell MCF-7 in vitro.It also inhibited the proliferation of human ermbryonic kidney cell 293.Their chemotherapeutic index were 26.907(24 h),15.307(48 h) and 10.264(72 h).CONCLUSION Gemcitabine is cytotoxic in human breast cancer cell MCF-7,and inhibits the proliferation of human ermbryonic kidney cell 293.

Key concepts: Gemcitabine, MCF-7, Cell growth, MTT assay, Cell, Cancer cell, Cancer, Cancer research

Related papers

Back to paper searchBrowse research topicsOriginal source
Nephrotoxicity of gemcitabine on human breast cancer cell MCF-7 and humanermbryonic kidney cell 293 invitro — Research Paper | ScholarLens